sodium selenate has been researched along with morphinans in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balboni, G; Bidlack, JM; Knapp, BI; Lazarus, LH; Neumeyer, JL; Peng, X; Salvadori, S; Trapella, C | 1 |
Bidlack, JM; Knapp, BI; Neumeyer, JL; Peng, X | 1 |
Bidlack, JM; Decker, M; Fulton, BS; Knapp, BI; Neumeyer, JL; Zhang, B | 1 |
Bidlack, JM; Decker, M; Knapp, BI; Neumeyer, JL; Si, YG | 1 |
Bidlack, JM; Fulton, BS; Knapp, BL; Neumeyer, JL | 1 |
Bidlack, JM; Neumeyer, JL; Scrimale, T; Sromek, AW; Zhang, B; Zhang, T | 1 |
6 other study(ies) available for sodium selenate and morphinans
Article | Year |
---|---|
New opioid designed multiple ligand from Dmt-Tic and morphinan pharmacophores.
Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Dipeptides; Ligands; Morphinans; Narcotic Antagonists; Radioligand Assay; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship; Tetrahydroisoquinolines | 2006 |
Pharmacological properties of bivalent ligands containing butorphan linked to nalbuphine, naltrexone, and naloxone at mu, delta, and kappa opioid receptors.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; CHO Cells; Cricetinae; Cricetulus; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ligands; Morphinans; Nalbuphine; Naloxone; Naltrexone; Radioligand Assay; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship | 2007 |
Univalent and bivalent ligands of butorphan: characteristics of the linking chain determine the affinity and potency of such opioid ligands.
Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Humans; Hydrolysis; Ligands; Morphinans; Protein Binding; Receptors, Opioid | 2009 |
Synthesis and opioid receptor binding affinities of 2-substituted and 3-aminomorphinans: ligands for mu, kappa, and delta opioid receptors.
Topics: Binding Sites; Ligands; Molecular Conformation; Morphinans; Narcotic Antagonists; Structure-Activity Relationship | 2010 |
Effect of linker substitution on the binding of butorphan univalent and bivalent ligands to opioid receptors.
Topics: Analgesics; Animals; CHO Cells; Cricetinae; Cricetulus; Ligands; Morphinans; Protein Binding; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2010 |
Synthesis and binding affinity of novel mono- and bivalent morphinan ligands for κ, μ, and δ opioid receptors.
Topics: Animals; Butorphanol; CHO Cells; Cricetinae; Cricetulus; Decanoates; Humans; Ligands; Morphinans; Protein Binding; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2011 |